Sabadell Asset Management’s Medtronic MDT Stock Holding History

Sabadell Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$8.85M	Buy	101,512 +46,801	+86%	+$4.03M	1.84%	23
2023 Q1	$4.39M	Sell	54,711 -33,519	-38%	-$2.73M	0.93%	40
2022 Q4	$7.09M	Buy	88,230 +3,573	+4%	+$290K	1.47%	27
2022 Q3	$7.2M	Sell	84,657 -3,100	-4%	-$279K	1.59%	23
2022 Q2	$7.68M	Buy	87,757 +20,218	+30%	+$2.05M	1.62%	18
2022 Q1	$7.59M	Sell	67,539 -1,310	-2%	-$138K	1.31%	17
2021 Q4	$7.49M	Buy	68,849 +1,993	+3%	+$231K	1.2%	22
2021 Q3	$8.38M	Buy	66,856 +559	+0.8%	+$72.4K	1.44%	17
2021 Q2	$8.23M	Buy	+66,297	New	+$8.32M	1.42%	17

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sabadell Asset Management's MDT Position: Q2 2023 in Review

Sabadell Asset Management increased its Medtronic (MDT) stake by 86% in Q2 2023, buying an estimated $4.03M and bringing the position to 101,512 shares worth $8.85M. The position accounts for 1.84% of the portfolio, ranked #23.

Sabadell Asset Management first reported a position in MDT in Q2 2021 and has held it in 9 quarters since. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

Sabadell Asset Management held 101,512 shares of Medtronic worth $8.85M as of Q2 2023.
Sabadell Asset Management bought 46,801 Medtronic shares in Q2 2023, an estimated $4.03M.
Medtronic made up 1.84% of Sabadell Asset Management's portfolio in Q2 2023, its #23 holding.
Sabadell Asset Management first reported a position in Medtronic in Q2 2021 and has held it in 9 quarters since.
2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.